1. Back Cover: Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer (EXP2 1/2021). Issue 1 (1st September 2021) Authors: Liu, Juan; Chen, Chao; Wei, Tuo; Gayet, Odile; Loncle, Céline; Borge, Laurence; Dusetti, Nelson; Ma, Xiaowei; Marson, Domenico; Laurini, Erik; Pricl, Sabrina; Gu, Zhongwei; Iovanna, Juan; Peng, Ling; Liang, Xing‐Jie Journal: Exploration Issue: Volume 1:Issue 1(2021) Page Start: ii Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Basal‐like and classical cells coexist in pancreatic cancer revealed by single‐cell analysis on biopsy‐derived pancreatic cancer organoids from the classical subtype. Issue 9 (20th July 2020) Authors: Juiz, Natalia; Elkaoutari, Abdessamad; Bigonnet, Martin; Gayet, Odile; Roques, Julie; Nicolle, Rémy; Iovanna, Juan; Dusetti, Nelson Journal: FASEB journal Issue: Volume 34:Issue 9(2020) Page Start: 12214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. BTN3A is a prognosis marker and a promising target for Vγ9Vδ2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC). (2nd January 2018) Authors: Benyamine, Audrey; Loncle, Céline; Foucher, Etienne; Blazquez, Juan-Luis; Castanier, Céline; Chrétien, Anne-Sophie; Modesti, Mauro; Secq, Véronique; Chouaib, Salem; Gironella, Meritxell; Vila-Navarro, Elena; Montalto, Giuseppe; Dagorn, Jean-Charles; Dusetti, Nelson; Iovanna, Juan; Olive, Daniel Journal: Oncoimmunology Issue: Volume 7:Number 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dendrimeric nanosystem consistently circumvents heterogeneous drug response and resistance in pancreatic cancer. Issue 1 (27th August 2021) Authors: Liu, Juan; Chen, Chao; Wei, Tuo; Gayet, Odile; Loncle, Céline; Borge, Laurence; Dusetti, Nelson; Ma, Xiaowei; Marson, Domenico; Laurini, Erik; Pricl, Sabrina; Gu, Zhongwei; Iovanna, Juan; Peng, Ling; Liang, Xing‐Jie Journal: Exploration Issue: Volume 1:Issue 1(2021) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Discovery and 3D imaging of a novel ΔNp63-expressing basal cell type in human pancreatic ducts with implications in disease. Issue 10 (30th July 2021) Authors: Martens, Sandrina; Coolens, Katarina; Van Bulck, Mathias; Arsenijevic, Tatjana; Casamitjana, Joan; Fernandez Ruiz, Angel; El Kaoutari, Abdessamad; Martinez de Villareal, Jaime; Madhloum, Hediel; Esni, Farzad; Heremans, Yves; Leuckx, Gunter; Heimberg, Harry; Bouwens, Luc; Jacquemin, Patrick; De Pa... Journal: Gut Issue: Volume 71:Issue 10(2022) Page Start: 2030 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer. Issue 9 (20th June 2016) Authors: Martinelli, Paola; Carrillo-de Santa Pau, Enrique; Cox, Trevor; Sainz, Bruno; Dusetti, Nelson; Greenhalf, William; Rinaldi, Lorenzo; Costello, Eithne; Ghaneh, Paula; Malats, Núria; Büchler, Markus; Pajic, Marina; Biankin, Andrew V; Iovanna, Juan; Neoptolemos, John; Real, Francisco X Journal: Gut Issue: Volume 66:Issue 9(2017) Page Start: 1665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts. Issue 4 (8th March 2017) Authors: Bian, Benjamin; Bigonnet, Martin; Gayet, Odile; Loncle, Celine; Maignan, Aurélie; Gilabert, Marine; Moutardier, Vincent; Garcia, Stephane; Turrini, Olivier; Delpero, Jean‐Robert; Giovannini, Marc; Grandval, Philippe; Gasmi, Mohamed; Ouaissi, Mehdi; Secq, Veronique; Poizat, Flora; Nicolle, Rémy; B... Journal: EMBO molecular medicine Issue: Volume 9:Issue 4(2017) Page Start: 482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Genetic inactivation of Nupr1 acts as a dominant suppressor event in a two-hit model of pancreatic carcinogenesis. Issue 6 (11th September 2013) Authors: Cano, Carla E; Hamidi, Tewfik; Garcia, Maria Noé; Grasso, Daniel; Loncle, Céline; Garcia, Stéphane; Calvo, Ezequiel; Lomberk, Gwen; Dusetti, Nelson; Bartholin, Laurent; Urrutia, Raul; Iovanna, Juan L Journal: Gut Issue: Volume 63:Issue 6(2014) Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression. (21st March 2022) Authors: Gouirand, Victoire; Gicquel, Tristan; Lien, Evan C; Jaune‐Pons, Emilie; Da Costa, Quentin; Finetti, Pascal; Metay, Elodie; Duluc, Camille; Mayers, Jared R; Audebert, Stephane; Camoin, Luc; Borge, Laurence; Rubis, Marion; Leca, Julie; Nigri, Jeremy; Bertucci, François; Dusetti, Nelson; Iovanna, Ju... Journal: EMBO journal Issue: Volume 41:Number 9(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool. Issue 10 (18th July 2022) Authors: Fraunhoffer, Nicolas A.; Abuelafia, Analía Meilerman; Dusetti, Nelson; Iovanna, Juan Journal: Cancer communications Issue: Volume 42:Issue 10(2022) Page Start: 1028 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗